Dariohealth Corp Stock Price, News & Analysis

DarioHealth Corp. (Nasdaq: DRIO) has been chosen as a digital health provider by Alabama Regional Medical Services (ARMS), a Federally Qualified Health Center focused on hypertension management. This partnership aims to utilize Dario's Remote Patient Monitoring (RPM) technologies to improve health outcomes for underserved populations in Alabama, where over 40% report high blood pressure. This contract marks Dario's second recent win in the RPM sector. The alliance is expected to enhance clinical care while supporting financial goals for ARMS.

DarioHealth Corp. (Nasdaq: DRIO) will have its Chief Medical Officer, Omar Manejwala, M.D., present at the DTx Europe virtual conference on July 14, 2021, at 5:55 a.m. EST. His presentation, titled "Rebalancing: Digital Therapeutics in a Post-Pandemic Healthcare System," will address the evolving role of digital therapeutics post-pandemic. The conference focuses on defining the success of digital therapeutics, emphasizing how these solutions can effectively manage health outcomes and costs. DarioHealth aims to enhance health management through its innovative digital therapeutics platform.

DarioHealth Corp. (Nasdaq: DRIO) presented new clinical research at the ADA 81^st Scientific Sessions, highlighting the effectiveness of its AI-driven personalization engine. The study involved 9,794 users, showing a 56% increase in engagement and a 12% reduction in average high-blood glucose readings over six months. A second study with 11,101 Type 2 diabetes members revealed a significant rise in target in-range readings from 28.4% to 54.8% over a year. These findings underscore Dario's commitment to enhancing health management through tailored interventions.

DarioHealth Corp. (Nasdaq: DRIO) has been selected as the digital health provider for Coastal Family Health Center, focusing on Remote Patient Monitoring (RPM) for hypertension. This initiative targets the high rate of hypertension in Mississippi, enabling better management for over 4,500 patients. Dario's AI-driven platform enhances patient-provider interactions and aims to reduce cardiac events and hospital admissions. The company plans to announce more B2B clients shortly, reinforcing its market position in digital therapeutics.

DarioHealth Corp. (NASDAQ: DRIO) has launched the Upright GO S, a wearable sensor designed to enhance back health accessibility. This product aligns with Dario's growth strategy, targeting both business partnerships and consumer markets. Currently, Dario boasts over 185,000 platform members. The Upright GO S aims to meet the rising demand for affordable musculoskeletal care, particularly as chronic back pain becomes prevalent among lower socioeconomic groups. The device is expected to diversify user engagement by utilizing AI-driven personalization, enhancing user experience across demographics.

DarioHealth Corp. (Nasdaq: DRIO) announced its inclusion in the Russell 3000® and Russell 2000® Indexes, effective June 28, 2021, following the annual reconstitution. This inclusion reflects Dario's growth as a pioneer in digital therapeutics and is expected to enhance company visibility among institutional investors, as approximately $9 trillion in assets are benchmarked to Russell indexes. CEO Erez Raphael highlighted the achievement as a testament to the team's efforts in revolutionizing chronic disease management through AI-powered solutions.